Literature DB >> 8593445

Effects of the ester moiety on stereoselective hydrolysis of several propranolol prodrugs in rat tissues.

K Takahashi1, S Tamagawa, H Sakano, T Katagi, N Mizuno.   

Abstract

The stereochemical characteristics of the hydrolysis of several ester-type prodrugs of propranolol, O-acetyl, O-propionyl, O-butyryl, O-pivaloyl and succinyl esters, were studied in phosphate buffer (pH 7.4), rat plasma and rat tissue homogenates. In phosphate buffer, no differences were observed in the hydrolysis rate between the esters of (R)- and (S)-propranolol. The effects of the ester moieties on the hydrolysis rate in phosphate buffer were in the following order: acetate > propionate > butyrate > succinate > pivalate. In rat plasma and tissue homogenates, the hydrolysis of the esters was accelerated, and stereoselective hydrolysis was observed. In plasma, the hydrolysis of the (R)-isomer was faster than that of the (S)-isomer except for the succinate ester. On the other hand, in the liver and intestine homogenates, the (S)-isomer was hydrolyzed faster than the (R)-isomer except for the succinate and pivalate esters in the liver homogenate. Also, the ratio of the hydrolysis rates (S/R) changed with the type of prodrug. As the length of the alkyl chain of the ester increased, the S/R ratio approached unity in liver and intestine homogenates but stayed almost constant in plasma. For the pivalate ester, stereoselective hydrolysis was observed in plasma and intestine homogenate but not in liver homogenate. The stereoselective hydrolysis of the succinate ester was observed only in intestine homogenate, but the S/R ratio was almost 1 in plasma, liver and intestine homogenates. No interconversion between (R)- and (S)-isomer was observed during the hydrolysis of any of the ester prodrugs. These results indicate that hydrolysis of ester-type prodrugs of propranolol occurs stereoselectively in rat tissues, and that its selectivity is dependent on the kind of tissue and prodrug.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593445     DOI: 10.1248/bpb.18.1401

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Retooling manganese(III) porphyrin-based peroxynitrite decomposition catalysts for selectivity and oral activity: a potential new strategy for treating chronic pain.

Authors:  Smita Rausaria; Mahsa M E Ghaffari; Andrew Kamadulski; Kenny Rodgers; Leesa Bryant; Zhoumou Chen; Tim Doyle; Michael J Shaw; Daniela Salvemini; William L Neumann
Journal:  J Med Chem       Date:  2011-11-22       Impact factor: 7.446

2.  Esterase-sensitive cyclic prodrugs of peptides: evaluation of an acyloxyalkoxy promoiety in a model hexapeptide.

Authors:  G M Pauletti; S Gangwar; F W Okumu; T J Siahaan; V J Stella; R T Borchardt
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

3.  Coumarinic acid-based cyclic prodrugs of opioid peptides that exhibit metabolic stability to peptidases and excellent cellular permeability.

Authors:  O S Gudmundsson; G M Pauletti; W Wang; D Shan; H Zhang; B Wang; R T Borchardt
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

4.  Acyloxyalkoxy-based cyclic prodrugs of opioid peptides: evaluation of the chemical and enzymatic stability as well as their transport properties across Caco-2 cell monolayers.

Authors:  A Bak; O S Gudmundsson; G J Friis; T J Siahaan; R T Borchardt
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

5.  N-octanoyl dopamine treatment of endothelial cells induces the unfolded protein response and results in hypometabolism and tolerance to hypothermia.

Authors:  Eleni Stamellou; Johann Fontana; Johannes Wedel; Emmanouil Ntasis; Carsten Sticht; Anja Becker; Prama Pallavi; Kerstin Wolf; Bernhard K Krämer; Mathias Hafner; Willem J van Son; Benito A Yard
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

6.  Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation.

Authors:  E Stamellou; D Storz; S Botov; E Ntasis; J Wedel; S Sollazzo; B K Krämer; W van Son; M Seelen; H G Schmalz; A Schmidt; M Hafner; B A Yard
Journal:  Redox Biol       Date:  2014-06-05       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.